Global Coronary Stents Market 2016-2018 & 2026 - Key Players, Competitive Strategies and Forecasts - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Coronary Stents Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to ResearchAndMarkets.com's offering.

The global coronary stents market was valued at US$ 6,216.7 Mn in 2017, and is expected to reach US$ 11,622.5 Mn by 2026, expanding at a CAGR of 7.3% from 2018 to 2026.

In the last 2 decades there has been technological advancement in the manufacturing of stents to counteract complication such as restenosis and stent-in-stent procedure. The only limitation the coronary stents market face is the exorbitant price of drug eluting stents and competition exerted by percutaneous coronary intervention.

Drug eluting stents are currently dominating the coronary stents market on account of key factors such as rising prevalence of coronary artery stenosis, technological advancement in the formulation of biodegradable polymers containing antiproliferative agents to prevent restenosis. Drug eluting stents are completely overshadowing the bare metal stents due to the inherent qualities it possess such as surface smoothness, thinner struts and durable metal alloys. Bioresorbable vascular scaffolds are gaining prominence for the treatment of coronary artery diseases due to key factors such as ability to restore the normal vessel shape and function, eliminate vessel irritation and inflammation and excellent patient compliance.

In the present scenario North America dominates the regional segment for coronary stents market. As per the statistics presented by Center for Disease Control and Prevention (CDC) annually 370,000 U.S. citizens die due to coronary artery disease. The American Africans are at a higher risk for cardiovascular disease on account of their unhealthy lifestyle, tobacco smoking and rise in obesity.

In Europe, the market growth is determined by the presence of key players such as Abbott Laboratories, Inc. and Medtronic, Plc. pioneering in manufacturing of coronary stents. Asia Pacific is set to register significant growth during the forecast period owing to the rising prevalence of cardiovascular ailment, rise in per capita income and growth in medical tourism.

Key Market Movements:

• Rising prevalence of cardiovascular complications and obesity in developed nations
• Growing public health awareness regarding heart ailments and adherence to effective treatment guidelines to drive market growth in developing nations
• Technological advancement in stent development to minimize restenosis and improve patient compliance

Key Topics Covered:

Chapter 1. Preface

Chapter 2. Executive Summary

Chapter 3. Coronary Stents Market: Dynamics and Future Outlook

Chapter 4. Global Coronary Stents Market, by Product

Chapter 5. Global Coronary Stents Market, by Geography

Chapter 6. Company Profiles

• Abbott Laboratories, Inc.
• Amaranth Medical, Inc.
• Biotronik SE & Co. KG
• B.Braun Melsungen AG
• Boston Scientific Corporation
• Cook Medical, Inc.
• C.R. Bard, Inc.
• Johnson & Johnson
• Medtronic, Plc
• Microport Scientific Corporation
• Terumo Corporation

For more information about this report visit https://www.researchandmarkets.com/research/ff2rgd/global_coronary?w=4